*Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupoli
‡Department of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece
†Institute of Neurology, Medical University of Vienna
§Institute of Pathology, Danube Hospital of Vienna
∥Department of Psychiatry, Medical Research Society Vienna D.C., Danube Hospital, Vienna, Austria
¶Department of Biological Sciences, Purdue University, West Lafayette, IN
P.P. and G.G.K. contributed equally.
This study was performed in the frame of the EU FP7 Project DEVELAGE (#278486; G.G.K.).
J.A.: performed the statistical analysis, interpreted findings, and wrote the manuscript. P.P. and G.G.K.: were responsible for study design, supervised analysis and interpreted findings, and wrote the manuscript. G.G.K.: supervised neuropathologic evaluations. T.S., M.T., M.G.: processed samples, performed Sanger sequencing analysis and participated in the interpretation of results and wrote the manuscript. S.H., A.R., G.G.K., and P.F.: were responsible for the VITA study including clinical, pathologic, and neuropathologic evaluations.
The authors declare no conflicts of interest.
Reprints: Gabor G. Kovacs, MD, PhD, Institute of Neurology, AKH 4J, Waehringer Gürtel 18-20, 1097 Vienna, Austria (e-mail: [email protected]).
